Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 11 Feb 2026
In this interview, Siegel highlights key points presented in his Maui Derm 2026 talk, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'
Read Full NewsUltragenyx seeks FDA accelerated approval for UX111 gene therapy in Sanfilippo syndrome, citing neurologic benefit and the use of cerebral spinal fluid heparan sulfate data.
Here's some of what is coming soon to NeurologyLive® this week.
AGNOS trial showed that monthly treatment with ofatumumab lowered NfL and GFAP in patients with early RRMS, signaling reduced nerve damage and bolstering first-line treatment potential.
Pediatric neurologist Charuta Joshi, MD, discussed global disparities in epilepsy for children and adolescents amid International Epilepsy Day, highlighting opportunities for education, stigma reduction, and improved care access.
The FDA issued a CRL for gene therapy RGX-121 in Hunter syndrome, citing trial design and biomarker doubts; Regenxbio seeks a meeting with the agency and resubmission.
New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis
1.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
2.
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'
3.
CAR-T Warning for Secondary Malignancies: Warranted or Not?
4.
Invest in generics as a lesson from the shortages of chemotherapy.
5.
Interleukin-6 may boost prediction of obesity-related cancers
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
3.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
4.
The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review
5.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XIV
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge